Anticoagulant Apixaban Superior to Warfarin for Reducing Brain Bleeds in Patients with Atrial Fibrillation
Mar 29, 2017
In a new analysis, patients with atrial fibrillation showed a substantially reduced risk of dangerous bleeding in the brain, known as intracranial hemorrhage, when taking the newer anticoagulant apixaban compared to those taking warfarin. The study also showed that taking aspirin increased the risk of intracranial hemorrhage, especially in older patients.
Statement from ASH President on Administration’s Proposed Cuts to NIH
Mar 16, 2017
ASH's President responded to the White House’s proposed fiscal year 2018 budget, which proposes a nearly $6 billion cut to the National Institutes of Health.
Statement From ASH President on Administration's Revised Executive Order on Immigration
Mar 07, 2017
In response to yesterday's signing of the Administration's revised executive order on immigration (Executive Order 13780), American Society of Hematology President Kenneth C. Anderson, MD, of the Dana-Farber Cancer Institute, issued the following statement.